alexa Adult Acute Myeloid Leukemia |OMICS International| Journal Of Nursing And Care

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

World Clinical Cancer Research and Diagnosis

Tokyo, Japan

2nd European Heart Congress

New York, USA

Global Summit on Petrochemicals

New York, USA

Adult Acute Myeloid Leukemia

The number of leukemia patients and survivors is growing. Acute Myeloid Leukemia (AML) is one of the most common types of adult leukemia, with at least 13,000 individuals diagnosed each year in the U.S. The incidence increases with age, with 16.0 per 100,000 individuals age ≥ 65 years compared to 1.7 per 100,000 individuals age <65. The average age at diagnosis in the U.S. is 66 years old. Approximately 60 to 70% of adult patients (aged 18-65 years) will achieve complete remission (CR), with 50-70% of first CR patients relapsing within 3 years. Approximately 22.6% of adult AML patients survive to five years . Though there are relapses beyond this time period , most 5-year survivors are considered cured.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on June, 2014